RxDoctor Payments Data

Joffre Olaya

Neurological Surgery · Orange, CANPI 1326255852

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (46.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 35.7% of the total. Reporting peaked in 2020 at $2,862 and has fallen 96.7% since, to $95 in 2025.

$9,120in general payments, 2019–2025

Across 72 payments — averaging $126.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biomarin Pharmaceutical Inc.$3K
  • Medtronic$1K
  • Monteris Medical Corporation$1K
  • Mentor Worldwide LLC$987
  • Neuropace, Inc.$715
  • Integra Lifesciences Corporation$382
  • plus $1K from 12 others
$40,343in research payments, 2019–2025

Across 22 payments — averaging $1833.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$35K
  • Neuropace, Inc.$6K

What the payments were for

  • Travel & lodging$1,63518%
  • Food & beverage$4,22846%
  • Education$3,25736%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,120 in reported general payments places this provider in the 60th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024
$6,280
Medicare patients
12
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in Orange

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →